Clinical Publications
SR. NO. | NAME OF PUBLISHED ARTICLE | LINKS | JOURNAL AND YEAR OF PUBLICATION | NUMBER OF PATIENTS | STUDY DESIGN | FOLLOW-UP | FIRST AUTHOR |
---|---|---|---|---|---|---|---|
Total Publications= 319 | |||||||
DIAGNOSTICS (Total = 3 articles) | |||||||
ABFIND COVID-19 Neutralizing Antibody Rapid Test-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against Covid-19 | Know More | medRxiv (Preprint) (2022)(2024) | 62 Patients | Single centre, prospective study | - | Jayanti Shastri, India |
EXIMO™ Blood Glucose Monitoring System-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | A post-marketing surveillance study to evaluate performance of the EXIMO™ blood glucose monitoring system | Know More | Journal of Clinical and Diagnostic Research (2017)(2024) | 1005 Patients | Non-randomized, single-center, post-marketing study | - | Sonia R. Chandnani, India |
CelQuant 360™ Automated Haematology Analyser-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Comparison between haematological parameters by the Merilyzer Celquant 360™ automated haematology analyser and Sysmex XP-100 haematology analyser with them manual methods | - | European Journal of Biomedical and Pharmaceutical Sciences (2018)(2024) | ||||
CARDIOVASCULAR (Total = 283 articles) | |||||||
BioMime™ Aura Sirolimus Coronary Eluting Stent System-Clinical Publications (Total = 2 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Endovascular reconstruction of popliteal and infrapopliteal arteries for limb salvage and wound healing in Patients with critical limb ischemia-A retrospective analysis | Know More | Indian Heart Journal (2016)(2024) | 34 Patients | Retrospective analysis | 3 Months | Uday B. Khanolkar, India |
Case Report (1) | |||||||
OR 01 | Multiple coronary microfistulas between left anterior descending artery and left ventricle following myocardial infarction | Know More | Heart India (2017)(2024) | 1 Patient | - | Post-procedural | Sulaiman S, India |
Evermine50™ EES-Drug Eluting Stent-Clinical Publications (Total = 13 articles) | |||||||
Original Research Articles (6) | |||||||
OR 01 | Clinical outcomes of world’s thinnest (50μm) strut biodegradable polymer coated everolimus eluting coronary stent system in real-world Patients | Know More | Cardiology Research (2018)(2024) | 251 Patients | Prospective, single-arm, single-center, post marketing study | 6 Months | Suresh V. Patted, India |
OR 02 | Clinical safety and efficacy of world’s thinnest (50μm), very long (>40 mm) everolimus eluting stent among real world Patients | Know More | American Journal of Cardiovascular Disease (2020)(2024) | 711 Patients | Prospective, observational study | 1 Year | Santosh Kumar Sinha, India |
OR 03 | Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus eluting stent in Patients with coronary artery disease | Know More | ARYA Atherosclerosis (2020)(2024) | 171 Patients | Retrospective study, single-arm, all-comers, single-center study | 1 Year | Suresh V. Patted, India |
OR 04 | Procedural safety and outcome of ultrathin strut stents (<60 μm) in the management of very long coronary artery stenosis (>30 mm)-A retrospective real-world study | Know More | American Journal of Cardiovascular Disease (2020)(2024) | 65 out of 156 Patients | Retrospective analysis, observational study | 8.4 ± 13.9 months mean follow up | Soumya Patra, India |
OR 05 | Clinical safety and performance of the world’s thinnest strut Evermine50™ Everolimus-eluting stent: A 24-month follow-up of Evermine50 EES-1 study | Know More | AsiaIntervention (2024)(2024) | 118 Patients | Prospective, single-arm, multi-center study | 2 Years | Sivaprasad K, India |
OR 06 | Safety and efficacy of Evermine50 Everolimus-eluting coronary stent system in patients with native coronary artery lesions: Three-year outcomes from a single-center | Know More | Journal of Cardiovascular and Thoracic Research (2025)(2024) | 251 Patients | Prospective, post-marketing, single-center study | 3 years | Suresh V Patted, India |
Editorial (2) | |||||||
OR 01 | Biodegradable polymer Evermine50™ everolimus eluting coronary stent system with ultrathin (50μm) strut | Know More | Integrative Clinical Medicine (2018)(2024) | - | - | - | Suresh V. Patted, India |
OR 02 | Less is more: a new “thin-king” for DES? | Know More | -(2024) | - | - | - | Azfar G. Zaman, United Kingdom |
Case Series (1) | |||||||
OR 01 | Device embolization during trans-radial percutaneous coronary intervention: Various approaches.A case series | Know More | IHJ Cardiovascular Case Reports (2021)(2024) | 3 Patients | - | - | Nagamani Alur Chikkabasavaiah, India |
Abstracts (4) | |||||||
OR 01 | Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus-eluting coronary stent system in treatment of patient with de novo coronary artery lesions | Know More | EuroIntervention (2018)(2024) | 171 Patients | Single-arm, single-center, non-randomized study | 1 Year | Suresh V. Patted, India |
OR 02 | Initial experience with ultrathin strut biodegradable polymer-coated everolimus-eluting coronary stent in coronary artery disease Patients | Know More | Journal of the American College of Cardiology (2018)(2024) | 110 Patients | Prospective, non-randomized, multi-center study | 6 Months | K. Sivaprasad, India |
OR 03 | 1-year clinical outcomes after percutaneous coronary intervention with biodegradable polymer ultra-thin strut everolimus-eluting coronary stent system | Know More | Journal of the American College of Cardiology (2019)(2024) | 251 Patients | Prospective, single-arm, single-center, real-world study | 1 Year | Suresh V. Patted, India |
OR 04 | One-year clinical outcomes of ultrathin strut everolimus eluting coronary system (50µm) for treatment of patient with de novo coronary artery lesions | Know More | AsiaIntervention (2019)(2024) | 171 Patients | Retrospective, single-arm, observational study | 1 Year | Suresh V. Patted, India |
BioMime Branch™ Sirolimus Eluting Coronary Side Branch Stent System-Clinical Publication (Total = 2 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Coronary Bifurcation Lesion Treatment with the BioMime™ Branch Sirolimus-Eluting Coronary Side-Branch Stent System: A Single-Center Experience | Know More | Cardiovascular Revascularization Medicine (2024)(2024) | 58 Patients | Retrospective, single-center study | 18 Months | Antonio L. Bartorelli, Italy |
Abstract (1) | |||||||
OR 01 | BioMime™ Branch-1: a randomized comparison of sirolimus-eluting coronary side branch stent systems and everolimus-eluting stent systems to assess safety and performance in Patients with de novo coronary bifurcation lesions | Know More | EuroIntervention (2020)(2024) | 18 out of 24 Patients | Prospective, active-control, open-label, multi-center, randomized clinical trial | 6 Months | Sethuraman Selvamani, India |
BioMime™ Morph Sirolimus Eluting Tapered Coronary Stent System- Clinical Publications (Total = 34 articles) | |||||||
Original Research Articles (14) | |||||||
OR 01 | First experience with the use of extra-long (40 to 60 mm) sirolimus-eluting stents in Patients with diffuse long | Know More | Kardilogiya (2017)(2024) | 85 Patients | Prospective, single-centre study | 1 Year | Yu G Matchin, Russia |
OR 02 | First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusion with the hybrid algorithm | Know More | Catheterization Cardiovascular Interventions (2018)(2024) | 49 out of 100 Patients | Observational retrospective study | 303 ± 179 Days | CarlZivelonghi, The Netherlands |
OR 03 | Clinical outcomes of novel long-tapered sirolimus-eluting coronary stent system in real-world Patients with long diffused de novo coronary lesions | Know More | Cadiology Research (2018)(2024) | 362 Patients | Retrospective, non-randomized, multi-centre study | 1 Year | Suresh V. Patted, India |
OR 04 | Comparison of clinical outcomes between very long stents and overlapping stents for the treatment of diffuse coronary disease in real clinical practice | Know More | Cardiovascular Revascularization Medicine (2018)(2024) | 628 Patients | Single-centre, retrospective, observational study | Median follow-up of 20 months | Alfonso Jurado Román, Spain |
OR 05 | Feasibility of implanting 50-60 mm-tapered drug eluting stents in chronic total occlusions | Know More | Cardiovascular Revascularization Medicine (2019)(2024) | 51 out of 54 Patients | Retrospective, single-arm study | A median follow-up of 330 (149-551) days | Gema Miñana, Spain |
OR 06 | Clinical experience with 12-month follow-up in Patients after implantation of a novel long tapered sirolimus drug-eluting stent | Know More | Advances in Interventional Cardiology (2019)(2024) | 32 Patients | Prospective clinical cohort study | 1 Year | Jakub Podolec, Poland |
OR 07 | Real-world experience with a tapered biodegradable polymer-coated sirolimus-eluting stent in Patients with long coronary artery stenosis | Know More | Cardiology Research (2020)(2024) | 272 Patients | Prospective, observational, and multi-centre study | 1 Year | Alessandro Lupi, Italy |
OR 08 | Feasibility and outcomes of left main to branch vessel PCI with novel tapered coronary stent in a tertiary care center: a real-world experience | Know More | Cardiovascular and Hematological Disorders Drug Targets (2021)(2024) | 41 Patients | Prospective, non-randomised, single-centre study | Median follow-up 20 months | T.R.Raghu, India |
OR 09 | One-year outcomes of novel BioMime™ Morph tapered stent in long and multiple coronary artery lesions | Know More | Anatolian Journal of Cardiology (2021)(2024) | 172 Patients | Observational, retrospective, single-center study | 1 Year | Yash Paul Sharma, India |
OR 10 | Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry | Know More | Angiology (2021)(2024) | 678 Patients | Observational, retrospective, and single-center study | Median follow-up 31 months | Martín Negreira-Caamaño, Spain |
OR 11 | Real-world experience with a 60 mm long stent in the setting of primary percutaneous coronary intervention | Know More | Heart Views (2022)(2024) | 88 Patients | Retrospective, observational analysis | 1 Year | Babu Thevan, Kingdom of Bahrain |
OR 12 | Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions | Know More | Cardiology Research (2024)(2024) | 88 Patients | Prospective, single-center, observational, real-world, post-marketing surveillance study | 3 Years | Suresh V. Patted, India |
OR 13 | Clinical outcomes of the BioMime™ Morph Coronary stent systme for long (30 to ≤ 56 mm length) coronary lesions: Three years follow-up of the Morpheus Global Registry. | Know More | Cardiovascular Revasecularization Medicine (2025)(2024) | 565 Patients | Prospective, single-arm, multicenter , observational, real-world registry | 3 Years | Pierfrancesco Agostoni, Belgium |
OR 14 | Long-Term Safety and Performance of BioMime Morph Sirolimus-Eluting | Know More | AsiaIntervention (2025)(2024) | 448 Patients | Prospective, multi-center, single-arm, real-world, post-marketing Surveillance study | 3 Years | Deepak Davidson, India |
Abstracts (8) | |||||||
OR 01 | Long term outcome after revascularization of long coronary artery lesions with very long or overlapping stents. Insights from the propensity score matched registry | Know More | Journal of the American College of Cardiology (2017)(2024) | 123 out of 377 Patients | Prospective, multi-centre registry | 2 Years | Piotr Buszman, Poland |
OR 02 | Experience of the management of complex long lesion by Indigenous BioMime™ Morph tapering stents | Know More | Journal of the American College of Cardiology (2017)(2024) | 52 Patients | Prospective, observational study | 9 Months | Manotosh Panja, India |
OR 03 | Real World Experience of the BioMime™ Morph tapered stent in a Tertiary Care Hospital | Know More | Journal of the American College of Cardiology (2018)(2024) | 122 Patients | Retrospective observational study | 26 Months | Sanjai Pattu Valappil, India |
OR 04 | Multicenter clinical outcomes of hybrid tapered sirolimus eluting coronary stent system with biodegradable polymer in long diffuse de novo coronary artery lesions | Know More | EuroIntervention (2018)(2024) | 362 Patients | Retrospective, multi-center, non-randomized study | 6 Months | Suresh V.Patted, India |
OR 05 | Initial experience with the novel BioMime™ Morph 40-60 mm long sirolimus-eluting tapered stent in long coronary lesions | Know More | EuroIntervention (2018)(2024) | 55 Patients | Prospective, single-centre study | 200 ± 50 Days | Anirban Choudhary, United Kingdom |
OR 06 | First Experience with very long coronary drug eluting stent | Know More | Journal of the American College of Cardiology (2019)(2024) | 63 Patients | Retrospective study | 1-3 Months | Farhat Fouladvand, Italy |
OR 07 | Clinical outcome of the world’s first tapered sirolimus eluting coronary stent system for long coronary lesions: a real-world experience | Know More | EuroIntervention (2020)(2024) | 435 Patients | Prospective, single-arm, multi-centre, real-world study | 1 Year | Deepak Davidson, India |
OR 08 | Longitudinal stent deformation detected on coronary CT in the novel BioMime™ 60mm long sirolimus-eluting tapered stent | Know More | EuroIntervention (2020)(2024) | 20 Patients | Prospective, single-centre study | 6-9 Months | Silvia Homs, Spain |
Case Reports (9) | |||||||
OR 01 | A report of successful procedural, clinical, and angiographic outcomes with a tapered stent of a patient in naturally tapered coronary vessel | Know More | Journal of Clinical and Diagnostic Research (2017)(2024) | 1 Patient | - | 1 Year | Rajendra Kumar Premchand, India |
OR 02 | First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina | Know More | Polish Heart Journal (2017)(2024) | 1 Patient | - | Post-procedural | Jakub Podolec, Poland |
OR 03 | Intravascular ultrasonography guided 60-mm long drug eluting tapered stent implantation in a long-calcified lesion in a patient with stable coronary artery disease | Know More | Advances in International Cardiology (2017)(2024) | 1 Patient | - | Post-procedural | Jakub Podolec, Poland |
OR 04 | Management of long complex CTO in LCX by indigenous BioMime™ Morph tapering stents from Meril | Know More | Journal of the American College of Cardiology (2017)(2024) | 1 Patient | - | Post-procedural | Manotosh Panja, India |
OR 05 | The perfect storm | Know More | Journal of the American College of Cardiology (2017)(2024) | 1 Patient | - | Post-procedural | Jayakhanthan Kolanthaivelu, Malaysia |
OR 06 | Tapered stents in long diffusely diseased coronary arteries-our experience | Know More | Journal of the American College of Cardiology (2017)(2024) | 1 Patient | - | 2 Years | T.R. Raghu, India |
OR 07 | Acute stent loss and its retrieval of a long, tapering Morph stent in a tortuous, calcified lesion | Know More | Cardiology Research (2018)(2024) | 1 Patient | - | Post-procedural | Santosh Kumar Sinha, India |
OR 08 | Successful treatment of tandem calcific right coronary artery stenoses with 50 mm tapered BioMime™ Morph stent guided by intravascular ultra sound and rotablation using a sheath less guide via the radial access | Know More | IHJ Cardiovascular Case Report (2019)(2024) | 1 Patient | - | 1 Year | Baskar Sekar, United Kingdom |
OR 09 | Use of BioMime™ Morph stent in treating left main triple vessel disease: a case report | Know More | The Egyptian Heart Journal (2020)(2024) | 1 Patient | - | 6 Months | Yash Paul Sharma, India |
Short Report (1) | |||||||
OR 01 | Initial Experience with the novel BioMime 60mm-long sirolimus-eluting tapered stent system in long coronary lesions | Know More | EuroIntervention (2017)(2024) | 50 Patients | Prospective clinical cohort study | Median follow-up 275 Days | Ernesto Valero, Spain |
Commentary (1) | |||||||
OR 01 | Innovative DES technologies from Meril | Know More | Minerva Cardiology and Angiology (2015)(2024) | - | - | - | Sanjeev Bhatt, India |
Editorial (1) | |||||||
OR 01 | Treatment of long coronary lesions with single stent: BioMime Morph sirolimus-eluting tapered coronary stent system | Know More | Heart India (2018)(2024) | - | - | - | Suresh V. Patted, India |
MeRes100™ Sirolimus Eluting BioResorbable Vascular Scaffold System- Clinical Publications (Total = 21 articles) | |||||||
Original Research Articles (6) | |||||||
OR 01 | First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the | Know More | EuroIntervention (2017)(2024) | 108 Patients | Prospective, multi-center, single-arm study | 1 Year | Ashok Seth, India |
OR 02 | Pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system for treatment of de novo native coronary lesions: a sub-study of MeRes-1 trial | Know More | Cardiology Research (2018)(2024) | 10 Patients | Prospective, single-arm, open-label pilot study | 90 days | Praveen Chandra, India |
OR 03 | Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial | Know More | EuroIntervention (2019)(2024) | 108 Patients | Prospective, multi-center, single-arm, open-label clinical trial | 3 Years | Ashok Seth, India |
OR 04 | Imaging and two-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: | Know More | Catheterization and Cardiovascular Interventions (2020)(2024) | 64 Patients | Prospective, multi-centre, single-arm, open-label study | 2 Years | Alexandre Abizaid, Brazil |
OR 05 | A real-world experience with a thin-strut Bioresorbable vascular scaffold system: a single-centre study | Know More | AsiaIntervention (2025)(2024) | 86 Patients | Retrospective, single-centre study | 1 Year | Puneet K. Verma, India |
OR 06 | Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries | Know More | Journal of Interventional Cardiology (2018)(2024) | Preclinical, controlled, comparative, and longitudinal study | 45, 90, 180 days, 1 year, and 2 years | Pawel Gasior, Poland | |
Abstracts (9) | |||||||
OR 01 | Quantitative angiographic analysis in Patients with de novo native coronary artery lesions treated with novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial | Know More | European Heart Journal (2017)(2024) | 108 Patients | First-in-man | Angiographic follow-up at 6-and 24 months | Ricardo Costa, Brazil |
OR 02 | First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial | Know More | Journal of the American College of Cardiology (2017)(2024) | 108 Patients | Prospective, multi-centre, first-in-human study | Angiographic follow-up at 6-months, clinical follow-up at 12 months | Ashok Seth, India |
OR 03 | Favorable outcomes for systemic pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system in treating de novo native coronary artery lesion: A sub study of MeRes-1 Trial | Know More | Journal of the American College of Cardiology (2017)(2024) | 10 Patients | Prospective, multi-centre study | 90 Days | Ashok Seth, India |
OR 04 | Real world performance of the novel MeRes100™ | Know More | Journal of the American College of Cardiology (2017)(2024) | 34 Patients (41 MeRes100 implanted) | Prospective, single-centre, registry | 9 Months | Marcos Ortega, Ecuador |
OR 05 | Two-year clinical and imaging outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffolds in de novo coronary artery lesions: the MeRes-1 trial | Know More | Journal of the American College of Cardiology (2018)(2024) | 108 Patients | Prospective, multi-centre, single-arm study | 2 Years | Ashok Seth, India |
OR 06 | Real world follow-up one year of the novel MeRes100 | Know More | Journal of the American College of Cardiology (2018)(2024) | 65 Patients (81 MeRes100 implanted) | Prospective, single-centre registry | 1 Year and OCT at 9 months | Marcos Ortega, Ecuador |
OR 07 | Implantation of thin-strut sirolimus-eluting bioresorbable vascular scaffold in Patients with de novo coronary artery lesions: 2-year clinical and 6-month imaging outcomes of the MeRes-1 extend trial | Know More | Journal of the American College of Cardiology (2019)(2024) | 64 Patients | Multi-centre, prospective, single-arm study | Imaging follow-up at 6 months and clinical follow-up at 2 years | Alexandre Abizaid, Brazil |
OR 08 | Clinical and imaging outcomes of thin-strut sirolimus eluting BRS in Patients with de novo coronary artery lesions: the MeRes-1 extend trial | Know More | EuroIntervention (2020)(2024) | 64 Patients | Prospective, multi-centre, single-arm study | Angiographic follow-up at 6 months and clinical follow-up upto 24 months | Alexandre Abizaid, Brazil |
OR 09 | The MeRes-1 Extend trial: 2-year clinical and 6-month imaging outcomes of thin-strut sirolimus-eluting BRS in Patients with de novo coronary artery lesions | Know More | Journal of the American College of Cardiology (2020)(2024) | 64 Patients | Prospective, multi-centre, single-arm study | Imaging follow-up at 6 months and clinical follow-up at 2 years | Alexandre Abizaid, Brazil |
Review Articles (3) | |||||||
OR 01 | Bioresorbable scaffold The emerging reality and future directions | Know More | Circulation Research (2017)(2024) | - | - | - | Yohei Sotomi, Netherlands |
OR 02 | Bioresorbable coronary scaffolds: deployment tips and tricks and the future of the technology | Know More | Methodist DeBakey Cardiovascular Journal (2018)(2024) | - | - | - | J. Ribamar Costa, Brazil |
OR 03 | Fully bioresorbable vascular scaffolds: Lessons learned and future directions | Know More | Nature Reviews Cardiology (2019)(2024) | - | - | - | Hiroyuki Jinnouchi, United States of America |
Book Chapter (1) | |||||||
OR 01 | MeRes100™ -A sirolimus eluting bioresorbable vascular | Know More | In Bioresorbable Scaffolds (2017)(2024) | - | - | - | Ashok Seth, India |
Editorial/ Editorial Commentary (2) | |||||||
OR 01 | A fresh look at bioresorbable scaffold technology: Intuition pumps | Know More | Indian Heart Journal (2017)(2024) | - | - | - | Sundeep Mishra, India |
OR 02 | Can the vanishing stent reappear? Fix the technique, or fix the device? | Know More | Journal of the American College of Cardiology (2017)(2024) | - | - | - | Spencer B. King, USA |
Mozec™ Rx PTCA Balloon Dilation Catheter- Clinical Publications (Total = 6 articles) | |||||||
Original Research Articles (3) | |||||||
OR 01 | Complex coronary interventions with the novel Mozec™ CTO balloon: The Mozart registry | Know More | Clinical Medicine Insights: Cardiology (2015)(2024) | 41 Patients | Prospective non- randomized, single-arm registry | 1 Year | Alessandro Lupi, Italy |
OR 02 | Clinical outcomes of a non-compliant balloon dilatation catheter: Mozec™ NC study | Know More | International Journal of Environmental Research and Public Health (2022)(2024) | 57 of 140 Patients | Post-marketing, single-centre, single-arm, retrospective study | 10.40 ± 0.26 months | Akshyaya Pradhan, India |
OR 03 | Safety and Performance of the MOZEC Sirolimus-Eluting | Know More | Cardiology Research (2025)(2024) | 141 Patients | Prospective, single-arm, multi-centre, real-world, post-marketing surveillance study | 24 Months | Rajendra Kumar Premchand Jain,India |
Abstract (1) | |||||||
OR 01 | How to make a deal with distal left main coronary artery type a trifurcation lesion | Know More | Journal of the American College of Cardiology (2017)(2024) | 1 Patient | - | - | Yusra Pintaningrum, Indonesia |
Review Article (1) | |||||||
OR 01 | Drug-coated balloons: technologies and clinical applications | Know More | Current Pharmaceutical Design (2018)(2024) | - | - | - | Huiying Ang, Singapore |
Case Report (1) | |||||||
OR 01 | Persistent stent thrombosis in a patient with non-ST segment elevation myocardial infarction and mild COVID-19 | Know More | Journal of Coronary Artery Disease (2022)(2024) | 1 Patient | - | Procedural Details | Mehmet Rasih Sonsoz, Turkey |
Metafor™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total = 5 articles) | |||||||
Original Research Articles (3) | |||||||
OR 01 | One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease | Know More | World Journal of Cardiovascular Diseases (2017)(2024) | 251 Patients | Retrospective, single-center, observational, post-marketing study | 1 Year | Sridhar Kasturi, India |
OR 02 | Safety and performance of sirolimus-eluting coronary stent system with biodegradable polymer: a retrospective analysis in real-world patient population | Know More | World Journal of Cardiovascular Diseases (2017)(2024) | 127 Patients | Retrospective, non-randomized, single-center study | 3.6 ± 0.6 Years | Vithala Surya Prakasa Rao, India |
OR 03 | Twelve-month clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients: a single-center experience | Know More | Indian Heart Journal (2021)(2024) | 141 Patients | Retrospective, single-centre, post-marketing, observational study | 1 Year | Pankaj Jariwala, India |
Abstracts (2) | |||||||
OR 01 | One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease | Know More | Journal of the American College of Cardiology: Cardiovascular interventions (2017)(2024) | 251 Patients | Retrospective, single center, observational, post-marketing study | 1 Year | Shridhar Kasturi, India |
OR 02 | Safety and clinical performance of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients | Know More | EuroIntervention (2020)(2024) | 141 Patients | Observational, single-center, post-marketing, retrospective study | 1 Year | Pankaj Jariwala, India |
NexGen™ Bare Metal Stent-Clinical Publication (Total = 1 articles) | |||||||
Abstract (1) | |||||||
OR 01 | Evaluation of safety and efficacy of NexGen-an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real-life patient population-the Polish NexGen™ Registry | Know More | Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej (2016)(2024) | 383 Patients | A prospective, multi-center registry | 1 Year | Krzysztof Milewski, Poland |
Osum™ Cobalt Chromium Coronary Stent System-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Clinical safety and performance of novel ultra-thin strut cobalt chromium bare metal stent implanted in real-world Patients with coronary artery disease | Know More | International Journal of Current Research (2018)(2024) | 467 Patients | Observational, non-randomized, retrospective, single-arm study | 2 Years | Mahesh Basarge, India |
Dafodil™ Pericardial Bioprosthesis-Clinical Publications (Total = 2 articles) | |||||||
Original Research Articles (2) | |||||||
OR 01 | Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial | Know More | Journal of Cardiothoracic Surgery (2020)(2024) | 60 Patients | First-in-human, prospective, single-arm, and multi-center trial | 1 Year | C.S. Hiremath, India |
OR 02 | Three-year Outcomes of Surgical Valve Replacement with Dafodil™ Pericardial Bioprosthesis: Dafodil™-1 Trial | Know More | Frontiers in Cardiovascular Medicine (2024)(2024) | 136 Patients | First-in-human, prospective, multi-center study | 3 Years | C.S. Hiremath, India |
CREDENCE™ BtK Sirolimus Eluting Bioresorbable Peripheral Scaffold System-Clinical Publication (Total = 1 articles) | |||||||
Abstract (1) | |||||||
OR 01 | 12-month clinical outcomes of sirolimus-eluting bioresorbable peripheral scaffold system following percutaneous transluminal angioplasty of below-the-knee arteries in Patients with critical limb ischaemia: the CREDENCE™ BtK-1 study | Know More | EuroIntervention (2020)(2024) | 30 Patients | First-in-man, prospective, multi-centre and open-label study | 1 Year | Vimal Someshwar, India |
Menox™ Liquid Embolic System-Clinical Publications (Total = 7 articles) | |||||||
Original Research Article (2) | |||||||
OR 01 | Intermixed dimethyl-sulfoxide based non adhesive liquid embolic agents delivered serially via the same micro catheter for cerebral AVM treatment | Know More | American Journal of Neuroradiology (2020)(2024) | 16 Patients | Single-centre, prospective study | Angiographic mean follow-up of 5.1 months | Alexander Sirakov, Bulgaria |
OR 02 | Comparison of a Novel Liquid Embolic System with Commonly Used Embolic Agents in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas: A Single-Center Experience | Know More | Journal of Clinical Medicine (2024)(2024) | 11 out of 19 Patients | Single center, retrospective study | 12 Months | Zarko Nedeljkovic, Serbia |
Case Report (2) | |||||||
OR 01 | Endovascular treatment of a post-traumatic pseudoaneurysm arising from a ruptured posterior tibial artery with Menox™ A case report | Know More | Radiology Case Reports (2021)(2024) | 1 Patient | - | 6 Months | Christina Aslanidi, Greece |
OR 02 | Embolization Using the Novel Menox Liquid Embolic System for Arteriovenous Fistulas: A Case Report | Know More | Journal of Clinical and Medical Image (2023)(2024) | 1 Patient | - | 6 Months | Audrius Sirvinskas, Lithuania |
Case Series (2) | |||||||
OR 01 | Extending endovascular embolization to type A spinal peri-medullary arteriovenous fistula using liquid embolic agent: technical nuances, challenges and initial outcomes | Know More | World Neurosurgery (2018)(2024) | 3 Cases | - | - | Virender Malik, India |
OR 02 | Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox™ in the endovascular treatment of cerebral arteriovenous malformations | Know More | Journal of NeuroInterventional Surgery (2018)(2024) | 24 Patients | Pilot study, retrospective analysis of prospectively collected data | 6 Months | Stanimir Sirakov, Bulgaria |
Review Article (1) | |||||||
OR 01 | Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas | Know More | Clinical Neuroradiology (2022)(2024) | - | - | - | Dominik F. Vollherbst, Germany |
Obtura™Vascular Closure Device- Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study | Know More | Journal of Endovascular Therapy (2024)(2024) | 134 out of 268 Patients | Prospective, randomized, controlled, multi-center trial | 3 Months | Tom Devasia, India |
Mammoth Balloon Catheter-Clinical Publication (Total = 1 articles) | |||||||
Original Research Articles (1) | |||||||
OR 01 | Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment | Know More | Journal of Clinical Medicine (2024)(2024) | 121 Patients | Retrospective, single-center cohort analysis | Post-procedure | Silvia Moscardelli, Italy |
BioMime™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total = 46 articles) | |||||||
Original Research Articles (11) | |||||||
OR 01 | First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vesselsresults from the meriT-1 trial | Know More | EuroIntervention (2013)(2024) | 30 Patients | Prospective, non-randomized, single-arm, single-centre, first-in-human study | 1 Year | Sameer Dani, India |
OR 02 | Late angiographic and clinical outcomes of the novel BioMime | Know More | AsiaIntervention (2016)(2024) | 250 Patients | Prospective, non randomized, single-arm, multicentre, phase II clinical study | 1 Year | Ashok Seth, India |
OR 03 | One-year outcomes of a BioMime sirolimus-eluting coronary stent system | Know More | Indian Heart Journal (2016)(2024) | 1161 Patients | Retrospective, multi-centre study | 1 Year | Rajendra Kumar Jain, India |
OR 04 | Randomized comparison of biodegradable polymer ultra-thin | Know More | EuroIntervention (2018)(2024) | 256 Patients | Prospective, multicentre, randomized, open-label, activecontrolled, and non-inferiority trial | 9 Months | Alexandre Abizaid, Brazil |
OR 05 | Single long stents versus overlapping multiple stents in the | Know More | The Journal of Tehran University Heart Center (2019) (2024) | 124 out of 1709 Patients | Historical cohort study | 1 Year | Alireza Amirzadegan, Iran |
OR 06 | Clinical outcomes of biodegradable polymer sirolimus-eluting stent in | Know More | EC Cardiology (2020)(2024) | 73 Patients | Retrospective, single-center , nonrandomized and observational study | Mean follow-up: 1.68±0.58 years | Binu Thankappan Gomathy, India |
OR 07 | Clinical follow-up of long non-tapered sirolimus-eluting coronary stent in | Know More | REC Interventional Cardiology (2022) (2024) | 696 Patients | Prospective, nonrandomized, multi-centre study | 1 Year | Enric Domingo Ribas, Spain |
OR 08 | A Randomized Controlled Trial Comparing BioMime SirolimusEluting Stent with Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial | Know More | Cardiology Research (2023)(2024) | 252 out of 256 Patients | Prospective, multi-center, randomized, active-controlled , non-inferiority trial | 2 Years | Alexandre Abizaid, Brazil |
OR 09 | Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in | Know More | Cardiology Research (2023) (2024) | 1188 patients | Retrospective, observational, single-center, post- marketing clinical follow-up study | 4 years | Girish Meennahalli Palleda, India |
OR 10 | Real-world evidence of BioMime sirolimus-eluting stent in obstructive | Know More | AsiaIntervention (2024)(2024) | 250 Patients | Prospective, single-arm, multicentre study | 5 Years | Upendra Kaul, India |
OR 11 | Safety and Efficacy of BioMime Sirolimus-eluting Stent System in | Know More | Cardiology Research Journal (2024)(2024) | 771 Patients | Post-marketing, multicenter, single-arm, observational clinical registry | 2 Years | Martin Hudec, Slovakia |
Meta Analysis (2) | |||||||
OR 01 | Newer generation ultra-thin strut drug- eluting stents versus older | Know More | Circulation (2018)(2024) | 170 out of 11,658 Patients | 170 out of 11,658 Patients | 1 Year | Sripal Bangalore, USA |
OR 02 | Long-term follow-up after ultrathin vs. conventional 2ndgeneration drugeluting stents: a systematic review and meta-analysis of randomized controlled trials | Know More | European Heart Journal (2021)(2024) | 170 out of 20,701 Patients | Meta-analysis of 16 trials that randomized 20,701 patients | Mean follow-up: 2.5 Years | Mahesh V. Madhavan, USA |
Abstracts (16) | |||||||
OR 01 | Moving towards biomimicrydevelopment of novel BioMime sirolimus eluting coronary stent system | Know More | The American Journal of Cardiology (2011)(2024) | 250 Patients | Single-arm, multi-center trial | 1-month clinical outcome and 8-month angiographic outcomes | Ashok Seth, India |
OR 02 | Impact of the new BioMime sirolimus-eluting stent in complex patients of daily practice-preliminary results of the meriT-2 study | Know More | Journal of the American College of Cardiology (2012)(2024) | 242 Patients | Prospective, nonrandomized, multi-center study | 8 months angiographic and 1-year clinical follow- up | Erlon de Abreu Silva, Brazil |
OR 03 | First-in-human evaluation of a novel sirolimus-eluting stent with a | Know More | Journal of the American College of Cardiology (2012)(2024) | 30 Patients | Prospective, nonrandomized, single-arm, single-center study | 8-month angiographic and 1-year clinical follow- up | Erlon de Abreu Silva, Brazil |
OR 04 | Efficacy of the novel BioMime sirolimus-eluting stents with a | Know More | Journal of the American College of Cardiology (2013)(2024) | 280 Patients | An angiographic sub-analysis of combined meriT-1 and meriT-2 prospective clinical trials | Angiographic analysis at 8 months of both studies | Ricardo A. Costa, Brazil |
OR 05 | How to make a deal with distal left main coronary artery type A trifurcation lesion | Know More | Journal of the American College of Cardiology (2017)(2024) | 1 Patient | Case study | Procedural Details | Yusra Pintaningrum , Indonesia |
OR 06 | Three-year clinical outcomes of BioMime sirolimus-eluting coronary | Know More | Journal of the American College of Cardiology (2017)(2024) | 250 Patients | Prospective, multi-center study | 3 Years | Ashok Seth, India |
OR 07 | Efficacy and safety of an ultrathin strut sirolimus eluting stent with | Know More | European Heart Journal Supplement (2018)(2024) | 588 Patients | Prospective, non-randomized, multi- centre, open label, observational registry | 9 Months | Ian Menown, United Kingdom |
OR 08 | Single long stent vs. overlapping multiple stents in the management of | Know More | EuroIntervention (2018)(2024) | 124 out of 1709 Patients | Historical cohort study | Mean follow-up: 441 ± 361 Days | A. Amirzadega, Iran |
OR 09 | Twelve-months clinical outcomes comparing biodegradable polymer | Know More | Journal of the American College of Cardiology (2018)(2024) | 170 out of 256 Patients | Prospective, multicentre, randomized, active controlled, noninferiority clinical trial | 1 Year | Alexandre Abizaid, Brazil |
OR 10 | Safety and efficacy of sirolimus-eluting stent system in all-comers real-world population with coronary artery stenosis: the MILES-GLOBAL study | Know More | Journal of the American College of Cardiology (2019)(2024) | 520 Patients | Multi-centre, prospective, single-arm, open-label study | 1 Year | Martin Hudec, Slovakia |
OR 11 | One-year clinical outcomes in patients implanted with biodegradable | Know More | Journal of the American College of Cardiology (2019)(2024) | 216 Patients | Retrospective single-center study | 1 Year | Mohit Gupta, India |
OR 12 | Clinical outcomes from real-world patients treated with | Know More | EuroIntervention (2020) (2024) | 1003 Patients | Retrospective, single- centre study | 2 Years | Vishal Batra, India |
OR 13 | Safety and performance of the biodegradable polymer-coated ultrathin | Know More | EuroIntervention (2020)(2024) | 216 Patients | Retrospective, single-centre study | 2 Years | Vivek Jindal, India |
OR 14 | Safety and efficacy of sirolimuseluting stent system in all-comers realworld population with coronary artery stenosis: the MILES-GLOBAL study | Know More | EuroIntervention (2020)(2024) | 520 Patients | Multi-center, prospective, single-arm, open-label study | 1 Year | Martin Hudec, Slovakia |
OR 15 | Primary efficacy and safety outcomesof a sirolimus-eluting thin-strut | - | EuroIntervention (2020)(2024) | 752 Patients | Prospective, non-randomized, multi-center, open-label, observationa l registry | 9 Months | Ian Menown, United Kingdom |
OR 16 | Strut coverage of the ultrathin BioMime stent: a single-centre | Know More | EuroIntervention (2020)(2024) | 28 out of 111 Patients | Prospective, post-marketi ng OCT analysis | 3 Months | Sudipta Chattopadhyay, United Kingdom |
Review Article (5) | |||||||
OR 01 | Moving towards Biomimicry-the development of the novel BioMime sirolimus-eluting coronary stent system | Know More | European Cardiology Review (2010) (2024) | - | - | - | Ashok Seth, India |
OR 02 | Advantages of novel BioMime sirolimus eluting coronary stent system. Moving towards biomimicry | Know More | Minerva Cardioangiologica (2012)(2024) | - | - | - | Upendra Kaul, India |
OR 03 | Innovative DES technologies from Meril | Know More | Minerva Cardioangiologica (2015)(2024) | - | - | - | Sanjeev Bhatt, India |
OR 04 | Novel bioabsorbable polymer and polymer-free metallic drugeluting stents | Know More | Journal of Cardiology (2018) (2024) | - | - | - | Jason Nogic, Australia |
OR 05 | Ultrathin struts drug-eluting stents: a state-of-the-art review | Know More | Journal of Personalized Medicine (2022)(2024) | - | - | - | Attilio Leone, Belgium |
Case Reports (8) | |||||||
OR 01 | IVUS guided stenting in moderate looking proximal coronary lesion | Know More | Journal of Indian College of Cardiology (2013)(2024) | 1 Patient | - | Post-procedural | Aniket Puri, India |
OR 02 | A percutaneous coronary intervention complication: coronary perforation | Know More | Journal of Turgut Ozal Medical Center (2013)(2024) | 1 Patient | - | Procedural Details | Abdulmek Yildiz, Turkey |
OR 03 | In-situ intra procedure left main coronary artery thrombosis | Know More | Journal of the American College of Cardiology (2014)(2024) | 1 Patient | - | Procedural Details | Puneet Verma, India |
OR 04 | Ostial circumflex stenting through left main-LAD stent: a challenge of | Know More | Journal of the American College of Cardiology (2015)(2024) | 1 Patient | - | Procedural Details | Gurunath P. Parale, India |
OR 05 | Chronic total occlusion intervention with no-flow tackled successfully | Know More | Journal of the American College of Cardiology (2015) (2024) | 1 Patient | - | Post-procedural | Arvind Kumar Kandoria, India |
OR 06 | Inter-coronary communication in chronic total occlusion: in search of recognition | Know More | Indian Heart Journal (2016)(2024) | 1 Patient | - | 6 Months | Mohit Gupta, India |
OR 07 | Bifurcation stenting. It’s easy. That’s what I thought | Know More | Journal of the American College of Cardiology (2016)(2024) | 1 Patient | Post-procedural | Mohan Ramachandran, Malaysia | |
OR 08 | Cuspal dissection of aorta during percutaneous coronary intervention | Know More | IHJ Cardiovascular Case Reports (2018)(2024) | 1 Patient | - | Post-procedural | Shilpa Jayaprakash, India |
Editorial Letter (1) | |||||||
OR 01 | Gone long, not wrong: BioMime Morph and a tale of coronary ambition | Know More | AsiaIntervention (2025)(2024) | - | - | - | Ignacio J. Amat-Santos, Spain |
Review Report/Scientific Reports (2) | |||||||
OR 01 | BioMime a sirolimus-eluting coronary stent system for the treatment of | Know More | Interventional Cardiology Review, Research, Resources (2011)(2024) | 30 Patients | Prospective, single-arm, single-cente r study | 1 Year | Clinical Trial Department, Meril Life Sciences, India |
OR 02 | Comparison of over expansionvcapabilities and thrombogenicity at the | Know More | Nature (2020)(2024) | - | - | - | Pawel Gasior, Poland |
Commentary (1) | |||||||
OR 01 | Very long stent technology: clinical and practical value | Know More | Future Cardiology (2013)(2024) | - | - | - | Ian Menown, United Kingdom |
Myval™ Transcatheter Heart Valve Replacement-Clinical Publications (Total = 140 articles) | |||||||
Original Research Articles (46) | |||||||
OR 01 | First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in Patients with severe symptomatic native aortic stenosis: the MyVal-1 study | Know More | EuroIntervention (2020)(2024) | 30 Patients | First-in-human, prospective, multi-center, single-arm, open-label study | 1 Year | Samin K. Sharma, USA |
OR 02 | Single-center experience of 105 minimalistic transfemoral transcatheter aortic valve replacement and its outcome | Know More | Indian Heart Journal (2021)(2024) | 105 Patients | Single-center, retrospective study | 30 Days | Ravinder Singh Rao, India |
OR 03 | Quantitative angiographic assessment of aortic regurgitation after transcatheter aortic valve implantation among three balloon-expandable valves | Know More | Global Heart (2021)(2024) | 108 out of 744 Patients | Retrospective, multi-center study | Post- implantation aortography | Hideyuki Kawashima, Ireland |
OR 04 | Operator preference and determinants of size selection | Know More | International Journal of Cardiology (2021)(2024) | 1115 Patients | Retrospective survey | - | Hideyuki Kawashima, Ireland |
OR 05 | Early clinical and haemodynamic matched comparison of balloon-expandable valves (MATCH-BALL) | Know More | Heart (2021)(2024) | 130 of 416 Patients | Prospective study | 30 Days | Jose R Delgado-Arana, Spain |
OR 06 | Next-generation balloon-expandable Myval™ transcatheter heart valve in low-risk aortic stenosis Patients | Know More | Catheterization and Cardiovascular Interventions (2021)(2024) | 100 Patients | Retrospective, multi-center registry | 30 Days | Mario Garcia-Gomez, Spain |
OR 07 | Early multicenter experience of a new balloon-expandable Myval™ transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits | Know More | Annals of Pediatric Cardiology (2021) (2024) | 7 Patients | Retrospective, multi-centre study | Median follow-up 16 months | Muthukumaran C Sivaprakasam, India |
OR 08 | Myval™ versus alternative balloon-and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances | Know More | International Journal of Cardiology (2021)(2024) | 135 out of 1131 Patients | Central corelab analysis, retrospective registry | 1 Year | Santos Martinez S, Spain |
OR 09 | First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study | Know More | Herz Cardiovascular Diseases (2021) (2024) | 25 Patients | Retrospective study | 3 Months | Ali Rıza Akyüz, Turkey |
OR 10 | Safety and efficacy of Myval implantation in Patients with severe bicuspid aortic valve stenosis-a multi-center real world experience | Know More | Journal of Clinical Medicine (2022)(2024) | 68 Patients | Retrospective study | 30 Days | Ahmed Elkoumy, Ireland |
OR 11 | Feasibility of precise commissural and coronary alignment with balloon-expandable TAVI | Know More | Revista Española de Cardiología (2022)(2024) | 10 Patients | Prospective study | 1 Month | Sandra Santos-Martınez, Spain |
OR 12 | Comparing two-year outcomes of balloon expandable Myval and self- expanding Evolut R in severe aortic valve stenosis | Know More | International Journal of Cardiology (2023) (2024) | 58 out of 166 Patients | Retrospective, single-center, observational, cohort analysis | 2 Years | Elisabetta Moscarella, Italy |
OR 13 | Transcatheter aortic valve implantation for severe bicuspid aortic stenosis- 2 years follow up experience from India | Know More | Frontiers in Cardiovascular Medicine (2022)(2024) | 70 BAV Patients of 287 | Multi-centre study | 2 Years | Vijay Kumar, India |
OR 14 | Transcatheter mitral valve-in-valve implantation with the balloon expandable Myval device | Know More | Journal of Clinical Medicine (2022)(2024) | 11 Patients | Multi-centre, retrospective study | 6 Months | Sara Blasco-Turrión, Spain |
OR 15 | Short-term outcome after transcatheter aortic valve replacement with a novel balloon-expandable valve | Know More | Netherlands Heart Journal (2022)(2024) | 120 Patients | Prospective, single-centre study | 6 Months | Jonathan Halim, The Netherlands |
OR 16 | Balloon-expandable TAVR bioprostheses: area or perimeter sizing? A prospective pilot study | Know More | Journal of Interventional Cardiology (2022)(2024) | 60 Patients | Prospective, single-centre study | 1 Year | Jonathan Halim, The Netherlands |
OR 17 | Transcatheter aortic valve implantation: a report on Serbia’s first systematic program | Know More | Frontiers in Cardiovascular Medicine (2022)(2024) | 13 out of 56 Patients | Cohort study | 30 Days | Darko Boljevic, Serbia |
OR 18 | Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in Patients with bioprosthetic left side heart valves failure:1-year follow-up from a multi-center experience | Know More | International Journal of Cardiology (2023) (2024) | 97 Patients | Prospective, multi-centre study | 1 Year | Elisabetta Moscarella, Italy |
OR 19 | Latest iteration balloon and self-expandable transcatheter valves for severe bicuspid aortic stenosis: The TRITON study | Know More | Revista Española de Cardiología (2023)(2024) | 122 out of 360 Patients | Multi-centre, retrospective registry | 30 Days | Ignacio J Amat-Santos, Spain |
OR 20 | One-year outcomes after Myval implantation in Patients with bicuspid aortic valve stenosis-a multi-centre real-world experience | Know More | Journal of Clinical Medicine (2023)(2024) | 62 Patients | Retrospective multi-centre study | 13.5 months median follow-up | Ahmed Elkoumy, Ireland |
OR 21 | Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registry | Know More | Cardiovascular Revascularization Medicine (2023) (2024) | 100 Patients | Single-arm, prospective registry | 2 Years | Luca Testa, Italy |
OR 22 | Angiographic quantification of aortic regurgitation following Myval Octacor implantation: Independent core lab adjudication | Know More | International Journal of Cardiology (2023)(2024) | 125 Patients | Retrospective, core lab analysis | - | Ahmed Elkoumy, Ireland |
OR 23 | Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity- Matched Study | Know More | Journal of Clinical Medicine (2023)(2024) | 120 out of 223 Patients | Retrospective, single-center study | 1 Year | Jonathan Halim, The Netherlands |
OR 24 | Early Outcomes of a Next- Generation Balloon-Expandable Transcatheter Heart Valve – The Myval System: A Single-Center Experience from Serbia | Know More | Journal of Cardiology and Cardiovascular Medicine (2023)(2024) | 13 Patients | Retrospective, single center study | 30 Days | Darko Boljevic, Serbia |
OR 25 | Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation | Know More | EuroIntervention (2023)(2024) | 113 Patients | International, multi-center, observational study | 1 Year | Juan Pablo Sánchez-Luna, Spain |
OR 26 | Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in Patients with extremely large aortic annuli in real- world scenario: first global, multi-centre experience | Know More | Catheterization and Cardiovascular Interventions (2023)(2024) | 10 Patients | Global Retrospective, observational multi-center study | 30 Days | Andreas Holzamer, Germany |
OR 27 | Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation: The PANTHEON International Project | Know More | JACC: Cardiovascular Interventions (2023)(2024) | 40 out of 69 Ballon expandable Patients | Retrospective study | 1 Year | Enrico Poletti, Italy |
OR 28 | Single center experience with the balloon‐expandable Myval transcatheter aortic valve system with the first 100 Patients: 30‐day and 1‐ year follow‐up | Know More | Catheterization and Cardiovascular Interventions (2023)(2024) | 100 Patients | Retrospective, single-center study | 1 Year | Balázs Magyari, Hungary |
OR 29 | Clinical comparison of a novel balloon-expandable versus a self-expanding transcatheter heart valve for the treatment of Patients with severe aortic valve stenosis: the EVAL Registry | Know More | Journal of Clinical Medicine (2022)(2024) | 58 of 166 Patients | Retrospective, single-centre study | 6 months | Monica Barki, Italy |
OR 30 | Clinical Outcomes Following Transcatheter Mitral Valve-in-Valve Replacement Using a Meril Myval Transcatheter Heart Valve | Know More | Heart, Lung and Circulation (2023)(2024) | 20 Patients | Retrospective, observational, single-centre study | 1 Year | Mullasari Ajit Sankardas, India |
OR 31 | Single-Center Experience with the Balloon Expandable Myval Transcatheter Aortic Valve System in Patients with Bicuspid Anatomy: Procedural and 30-Day Follow-Up | Know More | Journal of Clinical Medicine (2023)(2024) | 52 Patients | Retrospective, observational study | 30 Days | Balázs Magyari, Hungary |
OR 32 | Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis – A real world Indian experience (The OCTACOR India Study) | Know More | Cardiovascular Revascularization Medicine (2024)(2024) | 123 Patients | Multi-center, real-world observational registry | 30 Days | John Jose, India |
OR 33 | Multicenter Experience for Early and Mid-Term Outcome of MyVal Transcatheter Pulmonary Valve Implantation | Know More | Pediatric Cardiology (2024) (2024) | 53 Patients | Multi-center, observational study | 360 Days median follow-up | Mohamed Al Nasef, Saudi Arabia |
OR 34 | Clinical outcomes of the Myval transcatheter heart valve system in Patients with severe aortic valve stenosis: a two-year follow-up observational study | Know More | Archives of Medical Science (2024)(2024) | 207 Patients | Multi-centre, registry based, observational study | 2 Years | Teoman Kilic, Turkey |
OR 35 | LANDMARK trial: Randomised non-inferiority comparison of early outcomes of newer generation Myval THV series with contemporary valves (Sapien and Evolut THV series) in real-world Patients with severe symptomatic native aortic stenosis | Know More | The Lancet (2024) (2024) | 768 Patients | RCT | 30 Days | Andreas Baumbach, UK |
OR 36 | German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation Outcomes of the MYLAND (MYvaL germAN stuDy) Study | Know More | Journal of Clinical Medicine (2024)(2024) | 134 Patients | Investigator-initiated, multi-center, retrospective, observational study | 30 Days | Timm Ubben, Germany |
OR 37 | Early Outcomes of Transcatheter Aortic Valve Implantation With Next-generation Balloon-expandable Myval Transcatheter Heart Valve: Single-center Experience From Iraq | Know More | Journal of the Saudi Heart Association (2024)(2024) | 100 Patient | Prospective single-centre study | 30 Days | Khalid Amber, Iraq |
OR 38 | Initial experience with the Myval balloon expandable valve in Argentina | Know More | Revista Argentina de Cardioangiología Intervencionista (2024)(2024) | 300 Patients | Prospective multi-center registry | Post-procedure | Federico Blanco, Argentina |
OR 39 | Performance of balloon-expandable transcatheter bioprostheses in inoperable patients with pure aortic regurgitation of a native valve: The BE-PANTHEON international project | Know More | Cardiovascular Revascularization Medicine (2024)(2024) | 41 out of 144 Patients | Retrospective study | 1 year | Enrico Poletti, Italy |
OR 40 | Learning Curve for Starting a Successful Single-Centre TAVR Programme with Multiple Devices: Early and Mid-Term Follow-Up | Know More | Journal of Clinical Medicine (2024)(2024) | 11 out of 122 Patients | Retrospective study | 3 Years | Balázs Magyari, Hungary |
OR 41 | The Myval Balloon-Expandable Transcatheter Heart Valve Implant in Aortic and Mitral Interventions: A Single-Center Experience | Know More | Cureus (2025)(2024) | 15 Patients | Retrospective single- cohort observational study | 22 Months | Ramesh Patel, India |
OR 42 | SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial | Know More | The Lancet (2025)(2024) | 514 out of 1031 Patients | "Multicentre, all-comers, randomised, non- inferiority trial" | 1 Year | Christian Juhl Terkelsen, Denmark |
OR 43 | "Percutaneous Pulmonary Valve Implantation In Native | Know More | Health Science Reports (2025)(2024) | 17 patients | Multicenter registry | "Immediate results of 30.5 and 32 mm MyVal™ valves implantation" | João Luiz Langer Manica, Brazil |
OR 44 | Immediate and Early Outcomes Following Myval Octacor Transcatheter Heart Valve Implantation for the Treatment of Patients With Severe Aortic Valve Stenosis: The OCTACOR‐EU Study | Know More | Catheterization and Cardiovascular Interventions (2025)(2024) | 252 patients | An observational, retrospective, multicenter, investigator‐driven registry | 30 Days | Alfonso Ielasi, Italy |
OR 45 | Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals | Know More | EuroIntervention (2024)(2024) | 384 out of 768 Patients | Prospective, RCT | 30 Days | Niels van Royen, The Netherlands |
OR 46 | A new and easy parameter to predict the requirement for permanent pacemaker implantation after transaortic valve | Know More | Advances in Interventional Cardiology (2024)(2024) | 110 out of 180 Patients | Retrospective study | Post-procedure | Ahmet Özderya, Turkey |
Abstracts (14) | |||||||
OR 01 | Evaluation of balloon expandable transcatheter heart valve in the treatment of severe symptomatic native aortic stenosis: the first-in human MyVal-1 study | Know More | Structural Heart (2020)(2024) | 100 Patients | First-in-human, prospective, multi-centre, single-arm study | 1 Month | Ravinder Singh Rao, India |
OR 02 | Clinical and haemodynamic outcomes of Patients who underwent transcatheter mitral valve-in-valve replacement: one- month results | Know More | The American Journal of Cardiology (2020)(2024) | 10 Patients | - | 1 Month | Ravinder Singh Rao, India |
OR 03 | Implant of Myval transcatheter aortic valve in Patients with severe aortic stenosis | Know More | Structural Heart (2020)(2024) | 5 Patients | Prospective study | 30 days, 6 Months | Andrea Janet Robaina Barrios, Venezuela |
OR 04 | Safety and efficacy of Myval™ transcatheter heart valve for treatment of severe symptomatic aortic stenosis at 30‐days | Know More | Catheterization and Cardiovascular Intervention (2020)(2024) | 7 Patients | Retrospective review | 1 Month | Nayef A. Al Asiri, Saudi Arabia |
OR 05 | Early single-center experience with Meril’s Myval transcatheter heart valve | Know More | JACC: Cardiovascular Interventions (2022)(2024) | 39 Patients | Single-centre, single-arm, open label, prospective registry | 30 Days | Alberto Colella Cervone, Brazil |
OR 06 | Commissural/Coronary Alignment with the Novel Myval™ Octacor THV-The Octa Align Technique | Know More | JACC: Cardiovascular Interventions (2023)(2024) | 30 Patients | - | - | Pruthvi C. Revaiah, Ireland |
OR 07 | Win Ratio Analysis of the LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis | Know More | "JACC: Cardiovascular Interventions (2024)"(2024) | 768 Patients | "Multicenter, randomized, non-inferiority trial" | 30 Days | Akihiro Tobe, Ireland |
OR 08 | Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up | Know More | "JACC: Cardiovascular Interventions (2024)"(2024) | 401 out of 545 Patients | Multicentric analysis | 4 Years | Akash Jain, Spain |
OR 09 | Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial | Know More | "JACC: Cardiovascular Interventions (2024)"(2024) | 352 out of 706 Patients | Prospective randomized trial | 30 Days | Pieter Smits, The Netherlands |
OR 10 | Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) | Know More | JACC: Cardiovascular Interventions (2024)(2024) | Baseline 757, Before discharge 744, After 30 days 715 (Total 768) | Prospective randomized trial | 30 Days | Pieter Smits, The Netherlands |
OR 11 | Initial Experience With the Myval Balloon-Expandable Transcatheter Heart Valve in Argentina | Know More | JACC: Cardiovascular Interventions (2024)(2024) | 500 Patients | Prospective multi-center registry | - | Federico Blanco Argentina |
OR 12 | The Current Generation of THV: A Single-Center Propensity Score Match Analysis | Know More | JACC: Cardiovascular Interventions (2024)(2024) | 228 Patients | Single-center, propensity-score matching study | 1 Year | Matjaz Bunc, Slovenia |
OR 13 | “Smart” Analysis of the Landmark Trial - Early Outcomes | Know More | JACC: Cardiovascular Interventions (2025)(2024) | 125 of 245 (Total 768 Patients) | RCT | 30 Days | Patrick W. Serruys, Ireland |
OR 14 | Early Outcomes With Three TAVI Valves (Myval, Sapien, and Evolut Series) in Women - Substudy of Landmark Trial | Know More | JACC: Cardiovascular Interventions (2025) (2024) | 193 of 369 (Total 768 Patients) | RCT | 30 Days | Akihiro Tobe, Ireland |
Case Reports (35) | |||||||
OR 01 | Successful transcatheter aortic valve replacement in a kidney allograft patient on rapamycin | Know More | Indian Journal of Transplantation (2019)(2024) | 1 Patient | - | Procedural Details | Aashish Chopra, India |
OR 02 | First transcatheter pulmonary valve implantation-an Indian made valve | Know More | IHJ Cardiovascular Case Reports (2020)(2024) | 1 Patient | - | 6 Months | Muthukumaran Chinnasamy Sivaprakasam, India |
OR 03 | Simultaneous percutaneous coronary intervention and transcatheter aortic valve implantation in a very high-risk octogenarian patient-what’s ideal time? | Know More | IHJ Cardiovascular Case Reports (2020)(2024) | 1 Patient | - | 8 Months | Pankaj Jariwala, India |
OR 04 | Myval™ and mini-chimney stenting to prevent coronary obstruction during full root stent-less aortic valve-in-valve procedure | Know More | Cardiovascular Revascularization Medicine (2020)(2024) | 1 Patient | - | 6 Months | Alfonso Ielasi, Italy |
OR 05 | Successful management of left main coronary artery obstruction following transcatheter aortic valve implantation | Know More | IHJ Cardiovascular Case Reports (2020)(2024) | 1 Patient | - | Procedural Details | Viveka Kumar, India |
OR 06 | Tip-to-base lampoon to prevent left ventricular outflow tract obstruction in a valve-in-ring transcatheter mitral valve replacement: first LAMPOON procedure in turkey and first LAMPOON case for transseptal Myval™ implantation | Know More | Anatolian Journal of Cardiology (2021)(2024) | 1 Patient | - | 1 Month | Teoman Kılıç, Turkey |
OR 07 | Transcatheter tricuspid valve-in-valve implantation with a novel balloon expandable Myval THV | Know More | The Annals of Thoracic Surgery (2021)(2024) | 1 Patient | - | 1 Month | Bilge Duran Karaduman, Turkey |
OR 08 | First-in-man valve-in-valve with the new balloon-expandable Myval™ transcatheter heart valve in a failed sutureless perceval bioprosthesis | Know More | Journal of Cardiac Surgery (2021)(2024) | 1 Patient | - | 30 Days | Igor Belluschi, Italy |
OR 09 | Transcatheter aortic valve implantation for aortic insuffiency in Patients with left ventricular assistance | Know More | Giornale Italiano di Cardiologia (2021)(2024) | 1 Patient | - | Post-procedural | Marco B. Ancona, Milan, Italy |
OR 10 | Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32mm Myval transcatheter heart valve | Know More | Catheterization and Cardiovascular Interventions (2021)(2024) | 1 Patient | - | 1 Year | Alejandro Rodríguez Ogando, Spain |
OR 11 | Transcatheter treatment tricuspid regurgitation by valve-in-ring implantation with a novel balloon-expandable Myval™ THV | Know More | Clinical vignette Kardiologia Polska (2022)(2024) | 1 Patient | - | Procedural Details | Hüseyin Ayhan, Turkey |
OR 12 | Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable device | Know More | Journal of Cardiac Surgery (2022)(2024) | 1 Patient | - | Procedural Details | Maria Drakopoulou, Greece |
OR 13 | Under-deployed TAVI with occluded left-main and severe aortic regurgitation; bailout chimney-in-chimney stenting and aggressive post-dilatation saves the day | Know More | Clinical Case Reports (2022)(2024) | 1 Patient | - | 1 Week | Pandula Athauda-arachchi, Sri Lanka |
OR 14 | Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration | Know More | European Heart Journal (2023)(2024) | 1 Patient | - | Post-procedural | Ying-Hwa Chen, Taiwan |
OR 15 | In-series transcatheter aortic valve replacement-in-transcatheter aortic valve replacement: ACURATE neo transcatheter heart valve degeneration successfully managed with Myval, avoiding coronary flow obstruction-a case report | Know More | Structural Heart (2023)(2024) | 1 Patient | - | 1 Month | Joao Felipe Barros de Toledo, Brazil |
OR 16 | Left ventricular assist device implantation combined with direct transaortic transcatheter valve-in-annular stent implantation after rescue mechanical Bentall procedure, a case report | Know More | BMC Journal of Cardiothoracic Surgery (2023)(2024) | 1 Patient | - | Post-procedural | Yuriy Pya, Kazakhstan |
OR 17 | Case report: a novel surgical technique for rapid valve-in-ring implantation into the native aortic annulus during left ventricular assist device implantation | Know More | Frontiers in Cardiovascular Medicine (2023)(2024) | 1 Patient | - | 6 Months | Yuriy Pya, Kazakhstan |
OR 18 | Pulmonary valve replacement in a large and tortuous right ventricle outflow tract with a 32 mm Myval valve under local anesthesia: challenges and technical considerations: a case report | Know More | European Heart Journal Case Reports (2023)(2024) | 1 Patient | - | 3 Months | Ali Houeijeh, France |
OR 19 | Case report: A complex case of valve-in-valve TAVI and left bundle branch pacing for severe aortic regurgitation with partially corrected type A aortic dissection and low ejection fraction | Know More | Frontiers in Cardiovascular Medicine (2023)(2024) | 1 Patient | - | 1 Year | Peter Marko Mihailovič, Slovenia |
OR 20 | Transcatheter aortic valve implantation for aortic regurgitation in HeartMate II supported patient using Myval THV: a case report | Know More | Oxford Medical Case Reports (2023)(2024) | 1 Patient | - | 1 Year | Mohamad Hamieh, Lebanon |
OR 21 | Technical Aspects for Transcatheter Aortic Valve Replacement with the Novel Balloon-Expandable Myval Octacor | Know More | JACC: Cardiovascular Intervention (2024)(2024) | 1 Patient | - | Post-procedural | Alfonso Ielasi, Italy |
OR 22 | Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic | Know More | Frontiers in Cardiovascular Medicine (2023)(2024) | 5 Patients | - | 1 Year | Abdurashi d Mussayev, Kazakhstan |
OR 23 | Direct aortic TAVI via anterior right mini thoracotomy using 32 mm myval for pure aortic regurgitation | Know More | Journal of Cardiothoracic Surgery (2024)(2024) | 1 Patient | Post procedural | Firas Aljanadi,UK | |
OR 24 | Coronary alignment by OctaAlign technique using | Know More | Journal of Cardiovascular Intervention (2024)(2024) | 1 Patient | - | Post procedural | Raja Ramesh Nukavarapu, India |
OR 25 | Transcatheter pulmonary valve implantation with custom-made 35-mm Myval™ transcatheter heart valve | Know More | Annals of Pediatric Cardiology (2024)(2024) | 1 Patient | - | Post procedural | Sivasubramanian Ramakrishnan, India |
OR 26 | Coronary Artery Protection with Chimney Stent in High-Risk Case of Coronary Occlusion in Transcatheter Aortic Valve Implantation | Know More | Journal of National Heart & Lung Society Nepal (2024)(2024) | 1 Patient | - | Post procedural | Chandra Mani Adhikari, Nepal |
OR 27 | Transcarotid aortic valve implantation using the novel | Know More | Polish Heart Journal (2024)(2024) | 1 Patient | - | Post procedural | Robert Sobczyński, Poland |
OR 28 | Transcatheter aortic valve implantation using balloon-expandable Myval transcatheter heart valve in a patient with bicuspid aortic valve with low-flow , low-gradient | Know More | Nepalese Heart Journal (2024)(2024) | 1 Patient | - | Post-procedural | Chandra Mani Adhikari Nepal |
OR 29 | Transcatheter Mitral Valve-in-valve Implantation with | Know More | Indian Journal of Clinical Cardiology (2024)(2024) | 1 Patient | - | Post-procedural | Suresh Kumar Paidi India |
OR 30 | Single-stage transcatheter mitral valve in valve implantation and paravalvular leak closure following failure of bioprosthetic valve and cardiogenic shock | Know More | IHJ Cardiovascular Reports (2024)(2024) | 1 Patient | - | Post-procedural | Dhamodaran Kaliyamoorthy India |
OR 31 | Successful Management of Myval Transcatheter Heart Valve Embolization into Abdominal Aortic Aneurysm During Transcatheter Aortic Valve Replacement | Know More | The Texas Heart Institute Journal (2024)(2024) | 1 Patient | - | 3 Months | Artemio García-Escobar, Spain |
OR 32 | First Transcatheter Valve-in-Valve Implantation With Myval Octacor Into a Failed Biological Prosthetic Aortic Valve in Serbia | Know More | Cardiology Research (2025)(2024) | 1 Patient | - | 6 Months | Valentina Balint Jovanovic, Serbia |
OR 33 | Reflections on transfemoral TAVI in dextrocardia with severe aortic regurgitation: Navigating anatomical complexity, off-label innovation, and future directions | Know More | International Journal of Cardiology Congenital Heart Disease (2025) (2024) | 1 Patient | - | 30 Days | Pandula Athauda arachchi, Sri Lanka |
OR 34 | Transcatheter Aortic Valve Replacement in Pure Native | Know More | Catheterization and Cardiovascular Interventions (2025)(2024) | 1 Patient | - | 30 Days | Jayesh Bhaskaran, India |
OR 35 | A challenging TAVI-in-TAVI with Balloon expandable | Know More | The Journal of Heart Valve Disease (2025)(2024) | 1 Patient | - | Dr. Dibya Ranjan Behera | |
Case Series (10) | |||||||
OR 01 | Trans-catheter valve-in-valve implantation with a novel balloon expandable device in Patients with bioprosthetic heart valve failure: A case series | Know More | Cardiovascular Revascularization Medicine (2020)(2024) | 5 Patients | - | Postprocedural (Upto 72 hrs) | Alfonso Ielasi, Italy |
OR 02 | First experiences with Myval™ transcatheter heart valve system in the treatment of severe pulmonary regurgitation in native right ventricular outflow tract and conduit dysfunction | Know More | Cardiology in the Young (2021)(2024) | 9 Patients | - | 9.8 months mean follow up | Ender Odemis, Turkey |
OR 03 | Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves | Know More | European Heart Journal (2022)(2024) | 2 Patients | - | 6 Years | Rebekka Vibjerg Jensen, Denmark |
OR 04 | TAVR in a large bicuspid anatomy using the XL-Myval™ 32mm | Know More | Frontiers in Cardiovascular Medicine (2022)(2024) | 3 Patient | - | 30 Days | Ahmed Elkoumy, Ireland |
OR 05 | Transcatheter mitral valve replacement (TMVR) for degenerated mitral valve bioprosthesis-A case series | Know More | IHJ Cardiovascular Case Reports (2023)(2024) | 5 Patients | - | 1 Month | Viveka Kumar, India |
OR 06 | Transcatheter Aortic Valve Implantation in Two High-Risk Patients with Low Coronary Ostial Heights Using the Novel Balloon Expandable MyvalTM Valve | Know More | Journal of Cardiology And Cardiovascular Medicine (2023)(2024) | 2 Patients | - | 1 Month | Raja Ramesh N, India |
OR 07 | A new simple technique for stabilizing the guidewire position within the left ventricle during transcatheter mitral valve‐in‐valve implantation | Know More | Catheterization and Cardiovascular Interventions (2024)(2024) | 2 Patients | - | Post-procedure | Kothandam Sivakumar, India |
OR 08 | Transcatheter aortic valve replacement in patients with a pre-existing prosthetic mitral valve: a single center | Know More | The Egyptian Heart Journal (2024)(2024) | 2 Patients | - | - | Oyewole A. Kushimo, Nigeria |
OR 09 | Prediction of Prosthetic Heart Valve Interaction During Transcatheter Double-Valve Replacement Using a Bench Model | Know More | Journal of American College of Cardiology (2025)(2024) | 3 Patients | - | - | Dr Vasu Nandhakumar, India |
OR 10 | Prosthetic Heart Valve Interactions and Their Clinical Significance During Transcatheter Left-Sided Double Valve Replacement | Know More | Journal of American College of Cardiology (2025)(2024) | 3 Patients | - | - | Dr Vasu Nandhakumar, India |
Editorial/ Editorial Letters (11) | |||||||
OR 01 | (Intermediate) size matters | Know More | International Journal of Cardiology (2021)(2024) | 1 Patient | - | - | Won-Keun Kim, Germany |
OR 02 | Transcatheter Pulmonary Valve Replacement With 32-mm Balloon-Expandable Prosthesis: Another Strategy in Mildly Dilated RVOT | Know More | JACC: Cardiovascular Interventions (2021)(2024) | - | - | - | Marco B. Ancona, Italy |
OR 03 | Transcarotid transcatheter aortic valve implantation with a novel balloon expandable Myval™ THV under the local anesthesia | Know More | Journal of Geriatric Cardiology (2022)(2024) | 1 Patient | - | - | Hüseyin Ayhan, Turkey |
OR 04 | Neocommissural/ Coronary Alignment with a Novel Balloon Expandable Transcatheter Aortic Valve First-in-Human Experience | Know More | JACC: Cardiovascular Interventions (2023)(2024) | 32 Patients | - | - | Pruthvi C.Revaiah, Ireland |
OR 05 | Bicuspid aortic valve: one of the last remaining challenges for the percutaneous treatment of aortic valve disease | Know More | Revista Española de Cardiología (2023)(2024) | - | - | - | Pilar Jimenez Quevedo, Spain |
OR 06 | Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now? | Know More | REC: Inteventional Cardiology (2024)(2024) | - | - | - | Ignacio J. Amat Santos, Spain |
OR 07 | LANDMARK trial: Update in study protocol | Know More | American Heart Journal (2024)(2024) | - | - | - | Akihiro Tobe, Ireland |
OR 08 | Novel 35-mm Balloon-Expandable Transcatheter Aortic Valve Replacement | Know More | JACC: Cardiovascular Interventions (2024)(2024) | - | - | - | John Jose, India |
OR 09 | BASELINE trial: update in study design | Know More | American Heart Journal (2024)(2024) | - | Protocol update | - | Rutger-Jan Nuis, The Netherlands |
OR 10 | Glimpse Into the Hemodynamic Performance of Myval Series vs Sapien | Know More | Structural Heart (2024)(2024) | - | - | - | Akihiro Tobe, Ireland |
OR 11 | Win ratio analysis of the LANDMARK trial | Know More | American Heart Journal (2025)(2024) | 768 patients | Multi-center, randomized, open-label, non-inferiority trial | 30 Days (10 Year follow-up) | Akihiro Tobe, Ireland |
Case Images (2) | |||||||
OR 01 | The novel balloon-expandable Myval transcatheter heart valve: systematic review of aortic, mitral, tricuspid | Know More | Canadian Journal of Cardiology (2024)(2024) | 1 Patient | - | - | Mariano Pellicano, Italy |
OR 02 | Transcatheter Aortic Valve in Failing Mechanical Aortic Valve | Know More | JACC: Cardiovascular Interventions (2024)(2024) | 1 Patient | - | - | Mario García Gómez, Spain |
Systematic Review (3) | |||||||
OR 01 | The novel balloon-expandable Myval transcatheter heart valve: systematic review of aortic, mitral, tricuspid and pulmonary indications | Know More | Revista Española de Cardiología (2024)(2024) | 74 Patients | - | - | Mario Garcia Gomez, Spain |
OR 02 | A systematic review and meta-analysis of the hemodynamics and outcomes of the Myval balloon-expandable valve in patients with severe aortic stenosis and with aortic regurgitation | Know More | IJC Heart & Vasculature (2025)(2024) | 2,864 patients from 29 studies | - | 2 Years | Elfatih A. Hasabo |
OR 03 | Effectiveness and Safety of Myval Versus Other Transcatheter Valves in Patients Undergoing TAVI: A Meta‐Analysis | Know More | Catheterization and Cardiovascular Interventions (2025)(2024) | Seven studies involving 3106 patients | - | 12 months | Anastasios Apostolos, Greece |
Review Articles (11) | |||||||
OR 01 | Current status of transcatheter aortic valve replacement in India | Know More | Cardiovascular Diagnosis and Therapy (2019)(2024) | - | - | - | Puneet Gupta, India |
OR 02 | Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosis | Know More | Future Cardiology (2020)(2024) | - | - | - | Samin K Sharma, USA |
OR 03 | Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”? | Know More | Annals of Translational Medicine (2020)(2024) | - | - | - | Matthias Renker, Germany |
OR 04 | An update on new generation transcatheter aortic valves and delivery systems | Know More | Journal of Clinical Medicine (2022)(2024) | - | - | - | Gloria Santangelo, Italy |
OR 05 | Prosthesis tailoring for Patients undergoing transcatheter aortic valve implantation | Know More | Journal of Clinical Medicine (2023)(2024) | - | - | - | Pier Pasquale Leone, USA |
OR 06 | Myval: a novel transcatheter heart valve for the treatment of severe aortic stenosis | Know More | Interventional Cardiology Review, Research, Resources (2023)(2024) | - | - | - | Ashok Seth, India |
OR 07 | A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval Octacor | Know More | Expert Review of Cardiovascular Therapy (2024)(2024) | - | - | - | Carolina Montonati,Italy |
OR 08 | Myval Transcatheter Heart Valve: The Future of Transcatheter Valve | Know More | Journal of Clinical Medicine (2024)(2024) | - | - | - | Teoman Kilic, Turkey |
OR 09 | Pediatric cardiac interventions: Innovations from India | Know More | Annals of Pediatric Cardiology (2024)(2024) | - | - | - | Mantoo Mohsin Raj, India |
OR 10 | Transcatheter Heart Valves—An Update on Types of Valves Available, Hardware Characteristics, and Patient Selection: An Indian Perspective | Know More | Indian Journal of Clinical Cardiology (2024) (2024) | - | - | - | Anoop Agrawal, India |
OR 11 | Myval transcatheter aortic valve series: An innovation in transcatheter aortic valve implantation technology | Know More | Interventional Cardiology (2024)(2024) | - | - | - | Teoman Kilic, Turkey |
Scientific Letter (1) | |||||||
OR 01 | Balloon-expandable Myval transcatheter aortic valve implantation. First experience in Spain | Know More | Revista Espanola de Cardiologia (2020)(2024) | 2 Patients | - | Discharge | Sandra Santos-Martınez, Spain |
Scientific Report (1) | |||||||
OR 01 | Angulation and curvature of aortic landing zone affect implantation depth in transcatheter aortic valve implantation | Know More | Scientific Report (2024)(2024) | 81 Implants | Observational, retrospective and single-center registry | Index Procedure | Riccardo Gorla, Italy |
Study Protocols (3) | |||||||
OR 01 | Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in Patients with severe symptomatic aortic valve stenosis: The LANDMARK trial | Know More | American Heart Journal (2021)(2024) | - | Prospective, randomized, multi-national, multi-centre, open-label, non-inferiority trial | - | Hideyuki Kawashima, Ireland |
OR 02 | Randomized comparison of TAVI valves: The Compare-TAVI trial | Know More | American Heart Journal (2024)(2024) | - | RCT | - | Christian Juhl Terkelsen, Denmark |
OR 03 | LANDMARK trial: Update in statistical analytical plan and protocol for the one-year report | Know More | American Heart Journal (2025)(2024) | - | Prospective, randomized, multi-national, multi-centre, open-label, non-inferiority tria | Protocol update | Akihiro Tobe, Ireland |
Comment (3) | |||||||
OR 01 | New-generation Myval transcatheter heart valve in severe aortic stenosis | Know More | THE LANCET (2024)(2024) | 384 Patients | RCT | 30 Days | Mariama Akodad, France |
OR 02 | Myval Balloon-Expandable Prosthesis in Argentina: Time to Take the Bull by the Horns | Know More | Revista Argentina de Cardioangiología Intervencionista (2024)(2024) | 300 Patients | Prospective multi-center registry | Post-procedure | Federico Blanco, Argentina |
OR 03 | Head-to-head comparison of balloon-expandable transcatheter heart | Know More | THE LANCET (2025)(2024) | 514 out of 1031 Patients | Multicentre, all-comers, randomised, non-inferiority trial | 1 Year | Mariama Akodad France |
ORTHOPEDIC (Total = 19 articles) | |||||||
Freedom® Total Knee System (Total = 19 articles) | |||||||
Original Research Articles (15) | |||||||
OR 01 | Restoration of femoral condylar anatomy for achieving optimum functional expectations: component | Know More | Reconstructive review (2016)(2024) | 172 Patients | Prospective, non-randomized, single-center study | 2 Years with average follow-up of 3.8 ± 0.9 Years | Sridhar Durbhakula, India |
OR 02 | Clinical evaluation of efficacy and performance of all-poly tibial Freedom® total knee system for treating osteoarthritis Patients: three-year follow up study | Know More | Journal of Clinical and Diagnostic Research (2017)(2024) | 158 Patients | Retrospective, post-marketing study, single-center | 3 Years | Avatar Singh, India |
OR 03 | Restoration of femoral condylar anatomy for achieving optimum functional expectations: continuation of an earlier study at 5-year minimum follow-up | Know More | Reconstructive review (2019)(2024) | 172 Patients | Prospective, single-center study | 5 Years | Sridhar Durbhakula, India |
OR 04 | Education, engagement, and provision of empathy by trained counselor enhances the patient satisfaction after | Know More | Journal of Clinical Orthopaedics and Trauma (2020)(2024) | 200 Patients | Prospective, randomized study | 52 Weeks | Sanjay Bhalchandra Londhe, India |
OR 05 | Early results of bone‑conserving high flexion posterior‑stabilized total knee system in Indian population | Know More | Indian Journal of Orthopaedics (2022)(2024) | 208 Patients | Prospective, continuous series study | 5 Years Average follow-up (years): 7.15 ± 1.23 (n = 208) | Sanjay Bhalchandra Londhe, India |
OR 06 | Efficacy of the pre‑operative three‑dimensional (3D) CT scan templating in predicting accurate implant size and alignment in robot | Know More | Indian Journal of Orthopaedics (2022)(2024) | 30 Patients | Prospective, single-center study | - | Sanjay Bhalchandra Londhe, India |
OR 07 | A multi-centre retrospective study of the impact of body mass index on clinical and functional outcomes of total knee arthroplasty: An Indian prospective | Know More | Journal of Orthopaedic Reports (2024)(2024) | 259 Patients | Multi-centre retrospective analysis | 3 Years | Kunal Arneja, India |
OR 08 | Age wise comparative analysis of Patients undergoing total knee arthroplasty: a multicenter indigenous experience | Know More | International Journal of Research in Orthopaedics (2024)(2024) | 300 Patients | Prospective, multi-centre, real-world study | 3 Years | Ravi Teja Rudraraju, India |
OR 09 | A comprehensive comparative study on mid-term clinical and functional outcomes in Indian patients following bilateral total knee arthroplasty: assessing the impact of body mass index on post-total knee arthroplasty results | Know More | International Journal of Research in Orthopaedics (2024)(2024) | 190 Patients | Prospective, multi-center observational study | 3 Years | Karineravanda M. Ponnanna, India |
OR 10 | Comparison of Early Results Between Bone-Conserving | Know More | Journal of Orthopedic Research and Therapy (2024)(2024) | 280 Patients in Freedom TKA group | Prospective study | Mean follow up of 3.5 years (range, 2 to 5 years) | Young-Hoo Kim, Republic of Korea |
OR 11 | Comparative mid-term evaluation of unilateral and bilateral total knee arthroplasty utilizing metal-backed | Know More | Journal of Orthopaedic Reports (2025)(2024) | 408 Patients | Prospective, single-arm post-marketing surveillance study | 3 Years | Ponnanna Karineravanda Machaiah, India |
OR 12 | Continuation of a Currently Available Primary Total Knee Arthroplasty System Design: 10-Year Follow-Up of Earlier Studies at 2- and 5-Years | Know More | Journal of Orthopaedic Experience & Innovation (2024)(2024) | 172 Patients | Prospective study | 10 Years | Sridhar Durbhakula, India, |
OR 13 | Evaluation of the safety and efficacy of the fully automated active robotic system in robotic-assisted total knee arthroplasty | Know More | Journal of Clinical Orthopaedics and Trauma (2023)(2024) | 30 Patients | Single-center, prospective study | 6 Months | Sanjay Bhalchandra Londhe, India |
OR 14 | An Early Experience with a Novel Technique of Total Knee | Know More | Indian Journal of Orthopaedics (2022)(2024) | 3 Patients | Retrospective analysis | 2 Years | Sanjay Bhalchandra Londhe, India |
OR 15 | Mid-term Outcomes of Patella Resurfacing During Total Knee Arthroplasty (TKA): Clinical, Functional, and Radiographic Insights | Know More | Cureus (2024)(2024) | 74 Patients | Prospective, multicenter, single-arm, real-world study | 3 Years | Supreet Bajwa, India |
Commentary (1) | |||||||
OR 01 | Challenges in successful management of haemophilic knee arthropathy: our experience in a tertiary center | Know More | Journal of Orthopaedics (2022)(2024) | 24 Patients | Retrospective chart review | 1 Year | Mohan Thadia, India |
Abstract (3) | |||||||
OR 01 | One-stage total knee arthroplasty with long stemmed tibia for traumatic tibial diaphysis fracture with co-existing osteoarthritis of the knee | Know More | Orthopaedics Proceedings (2022)(2024) | 3 Patients | - | 1 Year | Sanjay Bhalchandra Londhe, India |
OR 02 | Component size discrepancies and their influence on three-year outcomes in simultaneous bilateral total knee arthroplasty: A multicentral prospective study | Know More | Journal of Clinical Orthopaedics and Trauma (2024)(2024) | 166 Patients | Multicenter , Prospective Study | 3 years | Kunal Aneja, India |
OR 03 | Can the subvastus approach for total knee arthroplasty help in achieving high flexion in highflex knees? Results of 242 knees at four years | Know More | Orthopaedic Proceedings (2019)(2024) | 184 Patients | Retrospective, observational, real-world study | Mean follow-up 3.71 ± 0.98 Years | Nilen Shah, India |
ENDOSURGERY (Total = 14 articles) | |||||||
MERIZELLE Absorbable Hemostat- Clinical Publication (Total = 1 articles) | |||||||
Original Research Articles (1) | |||||||
OR 01 | The Safety and Effectiveness of MERIZELLE Oxidized Regenerated Cellulose in Achieving Hemostasis Across Various Surgical Procedures-A Prospective, Multi-Center, Post-Marketing Surveillance Study | Know More | Journal of Wound Care (2024)(2024) | 189 Patients | Prospective, Multi-Center, Post-Marketing Surveillance Study | 6 Months | Amey Patankar, India |
MITSU™ ABP Polyglactin 910 Suture-Clinical Publications (Total = 2 articles) | |||||||
Study Protocol (1) | |||||||
OR 01 | Evaluation of safety and efficacy of Polyglactin 910 suture in surgical incision closure: clinical study protocol for a randomized controlled trial | Know More | International Journal of Clinical Trials (2018)(2024) | 122 Patients | Prospective, multi-center, randomized, controlled, comparative, post-marketing and single-blinded | 6 Months | Asha Dixit, India |
Original Research Articles (1) | |||||||
OR 01 | Safety and Efficacy of triclosan-coated polyglactin 910 suture in prevention of surgical site infection in postpartum women: A randomized controlled trial | Know More | Journal of the Indian Medical Association (2018) (2024) | 122 patients | Prospective, multicenter, single-blinded (Patient blinded), randomized controlled trial | 6 Months | Asha Dixit, India |
MIRUS™ Disposable Haemorrhoids Stapler- Clinical Publications (Total = 2 articles) | |||||||
Original Research Articles (2) | |||||||
OR 01 | Comparison of conventional (CH) vs stapled haemorrhoidectomy (SH): three-yearss experience | Know More | Annals of International Medical and Dental Research (2017)(2024) | 150 Patients | Retrospective and comparative study | 1 Year | Kumar Gaurav, India |
OR 02 | Clinical outcomes of stapled hemorrhoidopexy using a novel three-row stapler for grade III/IV hemorrhoids: A single-center experience with literature review | Know More | Journal of Clinical Images and Medical Case Reports (2023)(2024) | 77 Patients | Retrospective single centre, cohort study | 2 Years | M Sadiq Kazi, India |
Mirus™ Circular Stapler- Clinical Publications (Total = 3 articles) | |||||||
Original Research Article (2) | |||||||
OR 01 | Our initial experience of three versus two rows circular stapler devices for stapled hemorrhoidopexy: a single institution review of 224 cases | Know More | International Surgery Journal (2020)(2024) | 224 Patients | Retrospective, observational, cohort study | - | Paritosh Gupta, India |
OR 02 | Clinical outcomes of stapled hemorrhoidopexy using a novel three-row stapler for grade III/IV hemorrhoids: A single-center experience with literature review | Know More | Journal of Clinical Images and Medical Case Reports (2023)(2024) | 77 patients | A single centre study | 2 years | M Sadiq Kazi, India |
Study Protocol Clinical Trial (1) | |||||||
OR 01 | Uni-center, patient-blinded, randomized, 12-month, parallel group, non-inferiority study to compare outcomes of 3-row vs 2-row circular staplers for colorectal anastomosis formation after low anterior resection for rectal cancer | Know More | Medicine (2019)(2024) | 154 Patients | Prospective, non-inferiority, 2-armed, parallel-group | - | Nikita A. Nekliudov, Russia |
Fiona™ Intrauterine Contraceptive Device-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Safety and performance of a levonorgestrel-releasing intrauterine contraceptive device: one-year outcomes of Fiona-1 clinical registry | Know More | Journal of the Indian Medical Association (2019)(2024) | 309 Patients | Prospective, open-label, single-arm post-marketing study | 1 Year | Jagruti Desai, India |
FILASILK™ Silk Suture-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | The safety and efficacy of clipless versus conventional laparoscopic cholecystectomy-our experience in an Indian rural center | Know More | MAEDICA Journal of Clinical Medicine (2018)(2024) | 160 Patients | Prospective study | 2 Months | Rikki Singal, India |
MEGASORB™ Polyglycolic Acid Suture-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study | Know More | Indian Society of Periodontology (2019)(2024) | Total 30 Patients. 10 patients with each suture | Randomized controlled double-blinded study | 1 Month | Prerna Ashok Karde, India |
MEGASORBPLUS™ Polyglycolic Acid Suture with Chlorhexidine-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study | Know More | Indian Society of Periodontology (2019)(2024) | 10 out of 30 Patients | Randomized controlled double-blinded study | 1 Month | Prerna Ashok Karde, India |
MEGASORB RAPID™ Polyglycolic Acid Suture-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study | Know More | Indian Society of Periodontology (2019)(2024) | 10 out of 30 Patients | Randomized controlled double-blinded study | 1 Month | Prerna Ashok Karde, India |
ABSOMESH™ Polyglecaprone 25/ Polypropylene Mesh-Clinical Publication (Total = 1 articles) | |||||||
Original Research Article (1) | |||||||
OR 01 | A comparative study of open vs laparoscopic repair in umbilical and para umbilical hernias | Know More | Journal of Dental and Medical Sciences (2019)(2024) | 70 out of 156 Patients | Prospective, observational study | Post-operative | P. Venkata Buddha, India |